Posted inLondon Exchange
AstraZeneca’s Imfinzi approved in EU for treatment of extensive-stage small cell lung cancer
The approval by the European Commission was based on positive results from the Phase III CASPIAN trial. LONDON: AstraZeneca's Imfinzi (durvalumab) has been approved in the European Union for the…
